Literature DB >> 18634279

[Platelet- derived growth factor--the construction, role and it's receptors].

Maria Mantur1, Olga Koper.   

Abstract

CONSTRUCTION: The platelet- derived growth factor (PDGF) is a small protein which is produced by many cells. PDGF was originally identified in platelets and in serum. It is a dimeric molecule consisting of disulfide- bonded, structurally similar A- and B- polypeptide chains. There are four isoforms of PDGF: PDGF A, PDGF B, PDFG C and PDGF D. There are purified from the alpha-granules of the platelets. ROLE: PDGF is a critical regulator of mesenchymal cell migration and proliferation. It is essential for angiogenesis, embryogenesis and cancer development and progression. Clinical studies reveal that aberrant expression of PDGF and its receptors is often associated with a variety of disorders including atherosclerosis, fibroproliferative diseases of lungs and kidneys. RECEPTORS: There are two structurally related PDGF- receptors, each with its own variation in signaling mechanism. Each subunit of PDGF binds one receptor subunit, leading to receptor dimerization. The receptors are tyrosine kinases. PDGFR alpha binds all types of isoforms. PDGFR beta can bind only polypeptide B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634279

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  4 in total

1.  VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery.

Authors:  Carl C Schimanski; Friederike Schlaegel; Mareike Jordan; Markus Moehler; George Sgourakis; Daniel G Drescher; Peter R Galle; Hauke Lang; Ines Gockel
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

2.  Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.

Authors:  Mevlüde Inanç; Ozlem Er; Halit Karaca; Veli Berk; Metin Ozkan; Recep Saraymen; Ferhan Elmalı
Journal:  Med Oncol       Date:  2012-05-12       Impact factor: 3.064

3.  MUC1 regulates PDGFA expression during pancreatic cancer progression.

Authors:  M Sahraei; L D Roy; J M Curry; T L Teresa; S Nath; D Besmer; A Kidiyoor; R Dalia; S J Gendler; P Mukherjee
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

4.  Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.

Authors:  Danyang Liu; Yonglong Zhang; Yingze Wei; Guoyuan Liu; Yufeng Liu; Qiongmei Gao; Liping Zou; Wenjiao Zeng; Nong Zhang
Journal:  Oncotarget       Date:  2016-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.